Phil Bilodeau, MD

1.3K posts

Phil Bilodeau, MD banner
Phil Bilodeau, MD

Phil Bilodeau, MD

@phil_bilodeau

Neuroimmunology 🧠 🔥 clinician scientist @MGHNeurology, @BWHNeurology. Grad of @harvardneuroMDs & @mcgillmed.

Boston, MA Katılım Aralık 2011
1.6K Takip Edilen1.6K Takipçiler
Sabitlenmiş Tweet
Phil Bilodeau, MD
Phil Bilodeau, MD@phil_bilodeau·
Why has no one thought of opening a bar near a hospital and calling it PubMed
English
245
2.7K
22.2K
0
Phil Bilodeau, MD
Phil Bilodeau, MD@phil_bilodeau·
We defined a new composite endpoint of relapse and safety or tolerability failure, which will serve as the primary endpoint for our upcoming PCORI-funded comparative effectiveness NMOSD trial, scheduled to launch soon.
English
0
0
1
107
Phil Bilodeau, MD retweetledi
IJMSC
IJMSC@IJMSCtweets·
"We aim to compare the efficacy and safety of rituximab...with recently approved #NMOSD-specific #treatments—eculizumab, inebilizumab, satralizumab—& other common off-label NMOSD treatments—mycophenolate mofetil & azathioprine." doi.org/10.1212/NXI.00… @shamik_b @phil_bilodeau
IJMSC tweet media
English
0
2
6
346
Phil Bilodeau, MD
Phil Bilodeau, MD@phil_bilodeau·
I am very grateful to @PCORI for funding our clinical trial on the comparative effectiveness of immunotherapies in NMOSD. Huge shout-out to our entire team: @TheSumairaFDN, Prof. Friedemann Paul, and Dr. Marcelo Matiello, without whom this would not have been possible.
English
0
2
21
844
Phil Bilodeau, MD
Phil Bilodeau, MD@phil_bilodeau·
@varma_ashwin97 @morgancheatham Agreed. Beyond causal/Bayesian inference, we also need to train clinicians to understand how to read and criticize studies (let alone conduct research). People will use the results of clearly poorly conducted research because they don't have the tools to understand it.
English
1
0
1
41
Morgan Cheatham, MD
Morgan Cheatham, MD@morgancheatham·
the first 2 rotations of medical school should be clinical pathology and radiology. makes very little sense to send people into clinical settings to interpret diagnostic data with zero understanding of how that data is generated and interpreted
English
6
4
30
9.5K
Phil Bilodeau, MD retweetledi
Elias Sotirchos
Elias Sotirchos@ESotirchos·
Interesting study. Need to be careful though with potentially overinterpreting this and other retrospective observational studies purported to prove the effectiveness of early PLEX. My detailed rapid response to this article is here: jnnp.bmj.com/content/early/…
Journal of Neurology, Neurosurgery and Psychiatry@JNNP_BMJ

Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacks jnnp.bmj.com/content/early/… @NeuroVisionLab

English
1
6
14
3.1K
Rachael Camp, CFP®
Rachael Camp, CFP®@camp_wealth·
Rule of Thumb • 10-12% bracket: Roth • 22-24% bracket: choose either • 32% +: Traditional The only rule that survives here, in my opinion, is 10-12% Roth. Paying 10-12% on tax is rarely a bad idea. But don't stop here. It's important to adjust this for you.
English
2
1
22
5.3K
Rachael Camp, CFP®
Rachael Camp, CFP®@camp_wealth·
Roth vs Traditional is a difficult decision. So most people end up doing a 50/50 split. But the research shows there is an optimal way with a multi-six-figure impact. And I NEVER see people talking about this method. Sharing it here:
English
17
25
356
119.3K
Phil Bilodeau, MD
Phil Bilodeau, MD@phil_bilodeau·
Very important paper our lab led by Dr. Natalia Drosu. We identified DR15-restricted epitopes recognized by EBV-specific CD4 T cells. Findings support the use of antiviral therapies/antigen-specific deletion of EBV-targeting CD4 T cells in MS. tinyurl.com/48vfswkr
Phil Bilodeau, MD tweet media
English
1
15
42
6.6K
Phil Bilodeau, MD retweetledi
JCM MDPI
JCM MDPI@JCM_MDPI·
🔍Editor’s Choice Paper 🛎️Welcome to this review "The Impact of Anti-Amyloid Immunotherapies on Stroke Care". ✍️by @phil_bilodeau et al. @MarielKozberg 🔗More details: mdpi.com/2687472 @MediPharma_MDPI @harvardmed #mdpijcm #Stroke #neurotwitter
JCM MDPI tweet media
Mariel Kozberg@MarielKozberg

How will anti-amyloid immunotherapies and ARIA affect stroke care? @phil_bilodeau, John Dickson, and I review the latest data on ARIA in the context of acute stroke care and secondary stroke prevention here: secure-web.cisco.com/1xmfXF0oNepoSs…

English
0
2
1
1K
Phil Bilodeau, MD
Phil Bilodeau, MD@phil_bilodeau·
#RTwitter, any straightforward way of incorporating iptw weights into brms when doing a Bayesian analysis?
English
0
0
2
234